Introduction
============

Hallmarks of PD include the loss of dopaminergic neurons containing-TH in the *substantia nigrapars compacta* and the abnormal accumulation of α-syn protein in Lewy bodies ([@B52]; [@B57]; [@B17]). The role of α-syn in the pathogenesis of PD is not well-understood but extensive experimental data points to a neurotoxic role of high levels of the protein in its soluble and aggregated forms ([@B56]; [@B61]; [@B2]; [@B8]). The causes of PD are likely multi-factorial with genetic predisposition and environmental factors contributing to the pathogenesis of the disease. To date, studies focused on the contributions of dietary fat intake to the risk of PD have yielded inconsistent results ([@B62]). Epidemiological studies of dietary fat intake and PD have found either a positive association ([@B39]; [@B3]; [@B35]; [@B45]), no association ([@B33]; [@B59]), or protective effects ([@B1]; [@B12]; [@B19]; [@B49]; [@B38]; [@B37]). Studies focused on specific groups of fatty acids have provided little clarity. Indeed, while poly-unsaturated fatty acids (PUFAs) and mono-unsaturated fatty acids (MUFAs) have been shown to be protective in some stud possible neurodegeneration as thdies ([@B1]; [@B19]) and detrimental in another ([@B21]), sFFAs have shown positive associations ([@B39]; [@B3]; [@B35]; [@B12]) or no significant relationship with PD risk ([@B33]; [@B11], [@B12]; [@B48]). Additionally, *in vitro* studies have shown that while PUFAs increase α-syn oligomerization and insoluble aggregate formation, sFFAs did not ([@B54]; [@B4]). Many of these epidemiological studies utilized food frequency questionnaires without clarifying the specific role of each sFFAs. In studies carried out in mice, the n-3 PUFAs eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) have been shown to provide neuroprotective effects in animal models of PD ([@B6], [@B5]; [@B53]; [@B24]). Another study in which m-Thy1 mice were fed a diet enriched in DHA over a 10-month span showed improved survival but no major impact on the dopaminergic system, motor impairments, or brain α-syn levels ([@B6], [@B5]; [@B53]; [@B24]). Several other animal studies utilized high fat diets that aren't isocaloric and contain high levels of cholesterol; however these studies didn't determine the contribution of specific fatty acids ([@B14]; [@B7]). Therefore, the role of dietary fat in PD risk requires a more precise examination of the contributions of individual fatty acids including saturated fats to elucidate the effects of each fat on PD risk.

The brain contains six saturated fatty acids: myristic acid, palmitic acid, stearic acid, arachidic acid, behenic acid, and lignoceric acid ([@B36]). We determined the specific effects of a diet rich in palmitic acid, the most abundant sFFA in the body and diet, on key proteins involved in PD risk. PA has been shown to be increased in neurodegenerative disease brains with high levels of this fatty acid found in the frontal cortex of PD ([@B25]) and also in parietal cortex in AD ([@B29]). We fed m-Thy1 mice and their controls, the B6D2 mice, an isocaloric diet enriched in PA and examined the effects on the levels of two major hallmarks of PD, α-syn protein and TH, the rate limiting enzyme in dopamine synthesis in the *substantia nigra*. We chose the m-Thy1 mouse model that exhibits many similarities with PD ([@B51]). The m-Thy1 mouse model overexpresses full-length human wild-type α-synuclein under the murine Thy-1 promoter. They have been extensively characterized and exhibit threefold increase in α-syn protein at 5 months, and decreased TH at 8 months ([@B51]; [@B26], [@B27], [@B28]; [@B13]; [@B50]). Our data shows that the PA diet regulated the expression levels of α-syn, TH, dopamine and serotonin, which are all key proteins and neurochemicals involved in the pathogenesis of neurodegenerative diseases. It is currently unknown if diets rich in other saturated fatty acids such as myristic acid can have the same effects as a PA-enriched diet. Myristic acid has been shown to cause anxiolytic-like effects in rats ([@B16]) which suggests it has the ability to alter neurochemical signaling in the brain and also needs to be further explored. Additionally, myristic acid has been suggested to be protective against hyperphosphorylation of the TAU protein that is involved in many neurodegenerative diseases ([@B15]).

Materials and Methods {#s1}
=====================

Feeding Regimens
----------------

Mice overexpressing full-length human wild-type α-syn under the murine Thy-1 promoter on the X chromosome were procured from the Chesselet laboratory at the University of California, Los Angeles (UCLA). The corresponding background control B6D2F1/J mice (Stock \# 100006) were procured from The Jackson Laboratory (Bar Harbor, ME, United States). We used male animals in these studies because female mice have the ability to inactivate the X chromosome, which may contain the inserted human α-syn gene under the m-Thy1 promoter. All animal procedures were carried out in accordance with the U.S. Public Health Service Policy on the Humane Care and Use of Laboratory Animals and were approved by the Institutional Animal Care and Use Committee at the University of North Dakota (Protocol 1506-2). All animal experiments complied with the National Institutes of Health Guide for the Care and Use of Laboratory Animals (NIH Publications No. 8023, revised 1978). The mice were housed individually in ventilated cages at an ambient room temperature (23--25°C) and ambient relative humidity ranging between 50 and 70%. The mice were maintained on 12:12 h light:dark cycle and allowed access to food and water *ad libitum*. Both genotypes of 3-month-old male mice, m-Thy1 and their backcrossed wild-type B6D2 mice (*n* = 8--9 per group), were fed either a PA-enriched diet (custom-made, TD 1106162, Harlan Teklad, 2.2% w/w palmitic acid) or a control diet (custom made, TD 85172, Harlan Teklad, 0.8% w/w palmitic acid) for 3 months. The diets were isocaloric in relation to each other with the exception of palmitate and linoleate content and based on the NIH-07 open formula. The respective composition of the diets is shown in **Table [1](#T1){ref-type="table"}**. Necropsy was performed at six (6) months of age. The genotype of all mice was verified with PCR analysis of tail snip DNA via general endpoint PCR. The *HPRT* gene was used as the internal control with a forward primer of GAAGAGCTACTGTAATGATCAGTCAACGG and a reverse primer of GAGAGGTCCTTTTCACCAGCAAGC. The forward primer used for the human *SNCA* gene was GCTACTGCTGTCACACCCGTC and the reverse primer was GATGATGGCATGCAGCACTGG.

###### 

Composition of the control chow diet and palmitate-enriched diet.

  Components                   Control chow diet   Palmitic acid-enriched diet
  ---------------------------- ------------------- -----------------------------
  Proteins                     23.6% w/w           23.6% w/w
  Carbohydrates                65.8% w/w           65.8% w/w
  Total fat                    5.6% w/w            5.6% w/w
  Total energy                 4.08 kcal/gram      4.08 kcal/gram
  Myristic acid (14:0)         0.1% w/w            0.1% w/w
  Palmitic acid (16:0)         0.8% w/w            2.2% w/w
  Stearic acid (18:0)          0.2% w/w            0.2% w/w
  Palmitoleic acid (16:1)      Trace               Trace
  Oleic acid (18:1)            1.2% w/w            1.2% w/w
  Gadoleic acid (20:1)         Trace               Trace
  Linoleic acid (18:2 n6)      2.2% w/w            0.8% w/w
  Linolenic acid (18:3 n3)     0.2% w/w            0.2% w/w
  Arachadonic acid (20:4 n6)   Trace               Trace
  EPA (20:5 n3)                0.1% w/w            0.1% w/w
  DHA (22:6 n3)                0.3% w/w            0.3% w/w

Western Blotting Analysis
-------------------------

*Substantia nigra*-enriched fractions were prepared as previously described ([@B43], [@B44]) and as follows. *Substantia nigra*-enriched tissues (20 mg) were dounce homogenized in RIPA tissue lysis buffer (50 mM Tris, 150 mM NaCl, 0.1% SDS, 0.5% sodium deoxycholate, 1% Triton X, pH 7.4) supplemented with protease and phosphatase inhibitors. The samples were centrifuged at 5000 × *g* for 15 min and the supernatant harvested. Protein concentrations were determined by the Bradford protein assay method. Proteins (10 μg) were resolved on SDS-PAGE gels followed by transfer to a polyvinylidene difluoride (PVDF) membrane (Bio-Rad, Hercules, CA, United States) and incubation with the antibodies listed in **Table [2](#T2){ref-type="table"}**. The origin, source, and dilutions of the respective antibodies used for this study are compiled in **Table [2](#T2){ref-type="table"}**. β-Actin was used as a gel loading control. The blots were developed with enhanced chemiluminescence (Clarity^TM^ Western ECL blotting substrate, Bio-Rad, Hercules, CA, United States) and imaged using an Aplegen Omega Lum G System (Pleasanton, CA, United States). The analysis was performed using ImageJ (NIH, United States) software. The results were quantified by densitometry and represented as total integrated densitometric values. Data were analyzed using the non-parametric, unpaired Student's *t*-test with the Mann--Whitney *post hoc* test. Western blots are expressed as fold change over β-Actin (*n* = 4 for B6D2 mice, *n* = 3--4 for m-Thy1 mice) including three technical replicates.

###### 

List of antibodies used in the study.

  Antibody   Dilution   Host     Manufacturer     Catalog \#   RRID
  ---------- ---------- -------- ---------------- ------------ -------------
  α-syn      1:500      Rabbit   Cell Signaling   2642S        AB_10695412
  TH         1:500      Rabbit   Cell Signaling   2792S        AB_10691683
  pS^40^TH   1:500      Rabbit   Sigma Aldrich    T9573        AB_261823

Real Time-RT PCR
----------------

Total RNA was extracted from *substantia nigra*-enriched tissue with the QuickGene RNA cultured cell HC kit S (Autogen, Holliston, MA, United States). Total RNA (0.5 μg) was reverse transcribed into cDNA with qScript cDNA SuperMix (Quanta Biosciences, Gaithersburg, MD, United States). Real-time rtPCR was then performed on the cDNA with taqman probes for the *SNCA* (Mm01188700_m1) and *TH* (Mm00447557_m1) genes (Applied Biosystems, Foster City, CA, United States) and normalized to 18S rRNA. Data were analyzed using the non-parametric, unpaired Student's *t*-test with the Mann--Whitney *post hoc* test. Real-Time RT-PCR is expressed as fold change over 18S rRNA using the ΔΔC~T~ method (*n* = 4--5) including two technical replicates.

Immunohistochemistry
--------------------

The right cerebral hemispheres of m-Thy1 and B6D2 mice were sectioned using a freezing microtome. As previously described ([@B41]), multiple paraformaldehyde-fixed and sucrose-equilibrated tissues were embedded in a 15% gelatin (in 0.1 M phosphate buffer, pH 7.4) matrix to form sample blocks for simultaneous processing. The blocks were immersed in a 4% paraformaldehyde solution for 3--4 days to harden the gelatin matrix, followed by a 30% sucrose solution that was replaced every 2 days until the blocks were utilized. The blocks were then flash frozen using dry-ice/isomethylpentane, and 40 μm serial sections were cut using a freezing microtome. Serial sections (960 μm apart) were then immunostained using an anti-TH antibody (1:500 dilution) and an anti α-syn antibody (1:500 dilution, see **Table [2](#T2){ref-type="table"}** for detailed descriptions of antibodies). The antigens were visualized using a Vector ABC kit and DAB as the chromogen (Vector Laboratories, Inc., Burlingame, CA, United States) according to the manufacturer's protocols. The slides were dehydrated through a series of ethanol concentrations and Histo-Clear (National Diagnostics, Atlanta, GA, United States) before being coverslipped using Permount. Photomicrographs were taken using an upright Leica DM1000 microscope and a Leica DF320 digital camera system (*n* = 2).

Biogenic Amine Analysis Using HPLC-ECD
--------------------------------------

*Substantia nigra*-enriched tissues were shipped to the Neurochemistry Core at Vanderbilt University where biogenic amine analysis was performed. Briefly, tissue samples were homogenized using a tissue dismembrator in 100--750 ul of 0.1 M TCA, which contains 10^−2^ M sodium acetate, 10^−4^ M EDTA, and 10.5% methanol (pH 3.8). Ten microliters of homogenates were used for the protein assay. The samples were then spun in a microcentrifuge at 10,000 × *g* for 20 min, and the supernatant was removed for biogenic monoamine analysis. Protein concentrations were determined using a BCA Protein Assay Kit (Thermo Scientific). Ten microliters of tissue homogenate was distributed into a 96-well plate, and 200 l of mixed BCA reagent (25 ml of Protein Reagent A mixed with 500 μl of Protein Reagent B) was added. The plate was then incubated at room temperature for 2 h for color development. A BSA standard curve was run at the same time. Absorbance was measured using a plate reader (POLARstar Omega) purchased from BMG LABTECH Company.

Biogenic amine concentrations were determined using an Antec Decade II (oxidation: 0.65) electrochemical detector operated at 33°C. Twenty microliter samples of the supernatant were injected using a Water 2707 autosampler onto a Phenomenex Kintex C18 HPLC column (100 mm × 4.60 mm, 2.6 um). Biogenic amines were eluted with a mobile phase consisting of 89.5% 0.1 M TCA, 10^−2^ M sodium acetate, 10^−4^ M EDTA, and 10.5% methanol (pH 3.8). Solvent was delivered at 0.6 ml/min using a Waters 515 HPLC pump. Using this HPLC solvent, the biogenic amines were eluted in the following order: Noradrenaline, Adrenaline, DOPAC, Dopamine, 5-HIAA, HVA, 5-HT, and 3-MT. HPLC control and data acquisition were managed using Empower software. Isoproterenol (5 ng/mL) was included in the homogenization buffer for use as a standard to quantify the biogenic amines. Data were analyzed using the non-parametric, unpaired Student's *t*-test with the Mann--Whitney *post hoc* test and are expressed as ng/mg protein (*n* = 3) including three technical replicates.

Statistical Analysis
--------------------

Data were analyzed using the non-parametric, unpaired Student's *t*-test with the Mann--Whitney *post hoc* test. Statistical analysis was performed with GraphPad Prism software 6.07. Western blots are expressed as fold change over β-Actin (*n* = 4) including three technical replicates. Quantitative data from the western blotting analysis are presented as mean ± SEM with unit value assigned to control diet and the extent of differences among the samples being expressed relative to the unit value of control diet. Quantitative data for Real Time-rtPCR analysis are presented as mean ± SEM and expressed as fold-change from control diet. Real-Time RT-PCR for SNCA and TH is expressed as fold change over 18S rRNA using the ΔΔC~T~ method (*n* = 4--5) including two technical replicates.

Results
=======

PA-Enriched Diet Exhibit Increased α-Syn Expression Levels
----------------------------------------------------------

We examined the effects of a PA-enriched diet on α-syn protein levels and mRNA expression in the *substantia nigra*-enriched fractions from the B6D2 mice and found that 3 months of feeding with a PA-enriched diet significantly increased (*p* \< 0.05) α-syn protein levels compared to the control diet (**Figures [1A,B](#F1){ref-type="fig"}**). To determine whether the PA-enriched diet affected α-syn gene expression via transcription, we performed Real-Time RT-PCR and found that the *SNCA* gene was significantly increased (*p* \< 0.01) in mice fed PA-enriched chow (**Figure [1C](#F1){ref-type="fig"}**). We then performed immunohistochemistry and found that the PA-enriched diet that confirms increased positive staining of α-syn (**Figure [1E](#F1){ref-type="fig"}**) than the control diet (**Figure [1D](#F1){ref-type="fig"}**). This data suggests that a PA-enriched diet is capable of regulating α-syn at a transcriptional level in B6D2 mice.

![Palmitate (PA)-enriched diet exhibit increases α-syn expression in B6D2 mice. Representative western blot **(A)** and optical density **(B)** of α-syn in the *substantia nigra*-enriched fraction of brains from B6D2 mice showing that the PA diet significantly increases α-syn protein levels. **(C)** Real-time RT-PCR shows that the PA diet increases SNCA mRNA. Immunocytochemistry of the *substantia nigra* shows that the PA diet-fed mice exhibit increased α-syn immunoreactivity **(E)** compared to the control diet **(D)**. ^∗^*p* \< 0.05, ^∗∗^*p* \< 0.01 versus control diet.](fnins-12-00552-g001){#F1}

We also examined the effects of a PA-enriched diet on α-syn protein and mRNA expression levels in the *substantia nigra*-enriched fractions from m-Thy1 mice and found that 3 months of a PA-enriched diet feeding significantly increased (*p* \< 0.05) α-syn protein levels as demonstrated by western blotting (**Figures [2A,B](#F2){ref-type="fig"}**). To determine whether the PA-enriched diet also affects α-syn gene expression, we performed Real-Time RT-PCR and found that the *SNCA* gene was significantly increased (*p* \< 0.05) in mice fed PA-enriched diet (**Figure [2C](#F2){ref-type="fig"}**). The RT-PCR primers chosen were used to assess the effects of a PA-enriched diet on endogenous expression of mouse SNCA. Human primers were also used for the samples which showed no amplification in the aforementioned B6D2 mice while the m-Thy1 mice showed no significant amplification differences suggesting that the PA-enriched diet does not affect the m-Thy1 promotor upon which the inserted human SNCA is located (data not shown). This data suggests the elevated levels of α-syn are due to the induction of increased endogenous mouse α-syn. We then performed immunohistochemistry and found that the PA-enriched diet resulted in increased α-syn immunostaining (**Figure [2E](#F2){ref-type="fig"}**) compared to the control diet-fed mice (**Figure [2D](#F2){ref-type="fig"}**). The cellular localization of the protein in both strains of animals on both diets seems to be in the soma as we were unable to identify any significant differences in distribution in the nucleus. We did not observe lewy-body-like inclusions in addition to the increase in α-syn protein levels. A longer duration of the diet may lead to the formation of lewy-body-like inclusions and possible neurodegeneration as the diet seems to be causing detrimental effects in regard to increased α-syn but also elicits protective effects that will be elaborated upon in the forthcoming data. This data suggests that a PA-enriched diet is capable of regulating α-syn expression levels in m-Thy1 mice.

![Palmitate-enriched diet increases α-syn expression levels in m-Thy1-mice. Representative western blot **(A)** and optical density **(B)** of α-syn in the *substantia nigra*-enriched fraction of brains from m-Thy1-αsyn mice showing that the PA diet significantly increases α-syn. **(C)** Real-time RT-PCR shows that the PA diet also increases SNCA mRNA. Immunocytochemistry of the *substantia nigra* shows that PA diet-fed mice **(E)** exhibit more immunoreactivity to α-syn antibody than control diet fed mice **(D)**. ^∗^*p* \< 0.05 versus control diet.](fnins-12-00552-g002){#F2}

PA-Enriched Diet Increases TH Expression Levels
-----------------------------------------------

We examined the effects of a PA-enriched diet on TH protein and mRNA expression levels in the *substantia nigra*-enriched fractions of brains from B6D2 mice and found that 3 months of feeding with a PA-enriched diet significantly increased (*p* \< 0.05) TH protein levels compared to the control diet (**Figures [3A,B](#F3){ref-type="fig"}**). In addition, levels of phospho S^40^TH, the active form of TH ([@B23]) were also shown to be significantly increased (*p* \< 0.05) following PA-enriched diet feeding (**Figures [3C,D](#F3){ref-type="fig"}**). To assess whether the PA-enriched diet affects *TH* gene expression via transcription, we performed Real-Time RT-PCR and found that the *TH* gene expression was significantly increased (*p* \< 0.05) in mice fed the PA-enriched diet compared to control diet (**Figure [3E](#F3){ref-type="fig"}**). Immunohistochemistry shows that the PA-enriched diet increases TH staining (**Figure [3G](#F3){ref-type="fig"}**) compared with the control diet-fed mice (**Figure [3F](#F3){ref-type="fig"}**). This data suggests that in B6D2 mice, a PA-enriched diet is capable of regulating TH at a transcriptional and translational level.

![B6D2 mice on a PA diet exhibit increased TH and pS^40^TH expression. Representative western blot **(A,C)** and optical density **(B,D)** showing the PA diet significantly increases levels of TH and pS^40^TH respectively in the *substantia nigra*-enriched fraction of brains from B6D2 mice. Real-time RT-PCR shows that the PA diet significantly increases TH mRNA **(E)**. Immunocytochemistry shows that PA diet-fed mice exhibit increased immunoreactivity to TH antibody **(F)** compared to control diet-fed **(G)**. ^∗^*p* \< 0.05 versus control diet.](fnins-12-00552-g003){#F3}

In the *substantia nigra*-enriched fraction of m-Thy1 mice, the 3 months of feeding with a PA-enriched diet significantly increases (*p* \< 0.05) TH protein levels (**Figures [4A,B](#F4){ref-type="fig"}**). In addition, levels of pS^40^TH were also shown to be significantly increased (*p* \< 0.05) with the PA-enriched diet (**Figures [4C,D](#F4){ref-type="fig"}**). Real-Time RT-PCR shows that the *TH* gene was significantly increased (*p* \< 0.05) in mice fed the PA-enriched chow (**Figure [4E](#F4){ref-type="fig"}**). We then performed immunohistochemistry in the *substantia nigra* and found that the PA-enriched diet resulted in increased TH staining (**Figure [4G](#F4){ref-type="fig"}**) compared with the control diet-fed mice (**Figure [4F](#F4){ref-type="fig"}**). This data suggests that in m-Thy1 mice a PA-enriched diet can regulate TH at a transcriptional and translational level. Not only did the PA diet increase TH but it also increased pS^40^TH in both B6D2 and m-Thy1 mouse models.

![m-Thy1-αSyn mice on a PA diet exhibit increased TH and pS^40^TH expression. Representative western blot **(A,C)** and optical density **(B,D)** showing the PA diet significantly increases levels of TH and pS^40^TH respectively in the *substantia nigra*-enriched fraction of brains from m-Thy1-αSyn mice. Real-time RT-PCR shows that the PA diet significantly increases TH mRNA **(E)**. Immunocytochemistry shows that PA diet-fed mice exhibit increased immunoreactivity to TH antibody **(G)** compared to control diet **(F)**. ^∗^*p* \< 0.05 versus control diet.](fnins-12-00552-g004){#F4}

PA Diet Differently Affects Biogenic Amines
-------------------------------------------

We assessed the levels of various biogenic amines in the *substantia nigra*-enriched fraction of B6D2 mice fed the control or the PA diets and observed no significant differences in dopamine (DA) content (**Figure [5A](#F5){ref-type="fig"}**) or its metabolites DOPAC (**Figure [5B](#F5){ref-type="fig"}**) and HVA (**Figure [5C](#F5){ref-type="fig"}**) between the two feeding regimens. Also, no significant differences in noradrenaline (**Figure [5D](#F5){ref-type="fig"}**), serotonin (**Figure [5E](#F5){ref-type="fig"}**), and the serotonin metabolite 5-HIAA (**Figure [5F](#F5){ref-type="fig"}**) were observed. Although the PA-enriched diet increased the expression of α-syn and TH, this data suggests the diet does not alter normal biogenic amine content in B6D2 mice. In the *substantia nigra*-enriched fractions of m-Thy1 mice we observed reduced levels of DA (**Figure [6A](#F6){ref-type="fig"}**) and DOPAC (**Figure [6B](#F6){ref-type="fig"}**), and increased levels of serotonin (**Figure [6E](#F6){ref-type="fig"}**) in mice fed a PA-enriched diet, while HVA (**Figure [6C](#F6){ref-type="fig"}**), Noradrenaline (**Figure [6D](#F6){ref-type="fig"}**), and 5-HIAA (**Figure [6F](#F6){ref-type="fig"}**) levels were unchanged between PA-enriched and control diets.

![Biogenic amine analysis revealed no significant differences in biogenic amines between B6D2 mice on a control or PA diet. PA-enriched diet doesn't affect DA **(A)**, DOPAC **(B)**, HVA **(C)**, Noradrenaline **(D)**, Serotonin (5-HT) **(E)**, or 5-HIAA **(F)** content compared to control diet. Data is expressed as ng/mg protein.](fnins-12-00552-g005){#F5}

![Biogenic amine analysis shows significant differences in biogenic amine levels between control and PA diet-fed m-Thy1 mice. While PA-enriched diet reduced DA **(A)** and DOPAC **(B)**, it increased 5-HT content **(E)** and didn't significantly affect Noradrenaline **(D)**, HVA **(C)**, or 5-HIAA **(F)** levels. Data were analyzed using the non-parametric, unpaired Student's *t*-test with the Mann--Whitney *post hoc* test. Data is expressed as ng/mg protein. ^∗^*p* \< 0.05, ^∗∗^*p* \< 0.01 versus control diet.](fnins-12-00552-g006){#F6}

Discussion
==========

In this study, we determined the specific contribution of the fatty acid PA in regulating expression levels of α-syn and TH, two proteins that are tightly linked to PD, in the m-Thy1 mouse model of PD and its matched control the B6D2 mouse. We found that the PA-enriched diet increased α-syn protein levels and mRNA content in both strains of mice. We also found that in both strains of mice the PA-enriched diet increases the protein and mRNA levels of TH, the rate limiting enzyme in the synthesis of dopamine ([@B55]). Our results suggest that the PA diet may have both protective and destructive effects by increasing TH and α-syn expression levels respectively.

Palmitate (16:0) is the most abundant sFFA acid in the body and the most abundant sFFA in certain foods including meats, cheeses, and dairy products. It is also synthesized *de novo* in the body and makes up 24% of total fatty acids in our blood and 28% of total fatty acids in our CSF ([@B31]). Numerous *in vitro* studies have focused on various roles of palmitic acid. It has been shown to increase ER stress ([@B42]), proinflammatory cytokine expression in astrocytes and microglia ([@B32]; [@B60]), activation of TLRs via NFKβ ([@B46]), and to reduce the expression of insulin-degrading enzyme (IDE), a protease responsible for the degradation of amyloid-β, the accumulation of which is implicated in the pathogenesis of AD ([@B22]). However, a role of PA in pathological hallmark formation of PD-type synucleinopathy remain unknown. Human research studies of sFFA have found positive associations ([@B39]; [@B3]; [@B35]; [@B12]) or no significant relationship ([@B33]; [@B11], [@B12]; [@B48]) with PD risk. While these studies provide important information, they utilized food frequency questionnaires in which individuals described what they have consumed. This type of survey can be difficult to interpret because individuals may not accurately report what, when, and how much they consumed.

Abnormal accumulation of α-syn protein is a characteristic of PD and other synucleinopathies. While the cause of the accumulation remains unknown, genetic predisposition along with environmental factors are likely to contribute to the pathogenesis of PD. *In vitro* studies have shown that PUFAs increase α-syn oligomerization and insoluble aggregate formation while sFFAs do not ([@B54]; [@B4]). Additionally, α-syn has been proposed to act as a lipid carrier to shuttle fatty acids around the cell ([@B30]) and a previous study showed that when α-syn is ablated in primary astrocytes, PA incorporation into membranes is decreased ([@B9]). The increase in PA content in our study may therefore lead to increased α-syn expression, which could function to properly traffic the excess PA to lipid membranes or to the mitochondria for β-oxidation and might therefore be functioning as a protective measure to maintain normal lipid homeostasis.

Tyrosine hydroxylase is a very important enzyme in the synthesis of dopamine ([@B55]) and has been shown to decrease in PD ([@B58]; [@B63]). Short chained fatty acids have been shown to upregulate TH expression through a cAMP dependent mechanism ([@B40]; [@B20]) while the role of long chain saturated and unsaturated fatty acids remains to be determined. In this study, we found that a PA-enriched diet increases TH protein and mRNA expression in both strains of mice. cAMP response element binding protein (CREB) has been shown to be the mediator by which cAMP upregulates TH expression in PC12 cells ([@B47]). It is possible that longer chain fatty acids like palmitic acid may have the same effect on CREB activation and are yet to be determined in future studies. To the best of our knowledge, we are the first to show that a PA enriched diet can induce TH protein and mRNA expression. Elucidation of the mechanism by which PA enriched diet induces TH expression is of great importance in the search for disease altering therapies in PD.

We did not observe any significant difference in the levels of biogenic amines in the control B6D2 mice fed the PA-enriched diet compared to the control diet. However, dopamine and serotonin levels were significantly modulated by the PA-enriched diet in the m-Thy1 mice. Our findings demonstrating reduced dopamine content in m-Thy1 mice are intriguing as we show that the PA diet increases TH expression. The contrasting up-regulation of active pS^40^TH vs. reduction of dopamine levels in m-Thy1 mice is curious but may be potentially explained by the observation that a PA-enriched diet exhibits protective and detrimental effects at the same time. The m-Thy1 mice already have an overabundance of α-syn protein levels and the diet exacerbates this effect which may be leading to neuroinflammation and some dopaminergic neuronal death and hence a reduction in global dopamine. On the other hand, the PA-enriched diet clearly upregulates TH protein and mRNA expression and pS^40^TH protein levels in both strains of mice which may be acting as a protective effect. TH catalyzes the conversion of the amino acid [L]{.smallcaps}-tyrosine to [L]{.smallcaps}-3,4-dihydroxyphenylalanine ([L]{.smallcaps}-DOPA) ([@B30]). It does so by using molecular oxygen (O~2~), in addition to iron (Fe^2+^) and tetrahydrobiopterin as cofactors. Although pS^40^TH is increased in m-Thy1 mice, cofactors may not be present in the m-Thy1 mice leading to less dopamine production. TH is subject to feedback inhibition by all the catecholamines by competing for the binding site of TH with the pterin cofactor ([@B64]; [@B18]). Additionally, the observed significant increase in serotonin levels may be inhibiting the function of TH and pS40TH leading to the observed decrease in dopamine levels. Our speculation is supported by previous studies showing that serotonin can reduce the activity of TH. Indeed, serotonin treatment of undifferentiated human neuroblastoma LAN-5 cells led to a decrease in TH activity ([@B34]). As such, our findings that PA increases serotonin levels are of significance as an increase is desirable in many conditions such as depression that is frequently associated with PD presentation. The significant increase in serotonin could be explained by the fact that sFFAs have been shown to upregulate the serotonin receptor Htr2c and downregulate monoamine oxidase enzymes ([@B10]). The PA-enriched diet may thus result in more serotonin availability.

Conclusion
==========

In summary, we demonstrate that the PA-enriched diet induces an increase in α-syn and TH protein and mRNA expression in both B6D2 and m-Thy1 mice. To the best of our knowledge, our study is the first to show that a diet enriched in PA increases the levels of TH protein and mRNA in these mouse models. We also show that the PA-enriched diet does not affect biogenic amine content in control B6D2 mice but significantly changes dopamine and serotonin levels in m-Thy1 mice relative to control-fed mice. Altogether, our results demonstrate that a diet enriched in PA increases the levels of TH, and serotonin, an effect that can provide beneficial effects in a variety of conditions. Future studies are needed to elucidate the mechanisms by which a PA-enriched diet modulates these proteins.
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